Taken together, all these studies implicate PGRN in development and progression of PD, most likely through modulation of inflammatory responses; yet the specific mechanisms by which this occurs have yet to be explored and will be needed to inform on the therapeutic potential of PGRN replacement in sporadic PD and other parkinsonisms. Here, GRN is linked to Parkinsonism.